Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
McKinsey
Boehringer Ingelheim
Johnson and Johnson
Queensland Health
Citi
UBS
Express Scripts
Cipla

Generated: May 23, 2018

DrugPatentWatch Database Preview

PLIAGLIS Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Pliaglis, and what generic alternatives are available?

Pliaglis is a drug marketed by Taro Pharms and is included in one NDA. There is one patent protecting this drug.

This drug has seventeen patent family members in eleven countries.

The generic ingredient in PLIAGLIS is lidocaine; tetracaine. There are twenty-nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the lidocaine; tetracaine profile page.
Summary for PLIAGLIS
International Patents:17
US Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: 3
Clinical Trials: 9
Formulation / Manufacturing:see details
DailyMed Link:PLIAGLIS at DailyMed
Drug patent expirations by year for PLIAGLIS
Pharmacology for PLIAGLIS
Ingredient-typeAmides
Esters
Drug ClassAmide Local Anesthetic
Antiarrhythmic
Ester Local Anesthetic
Physiological EffectLocal Anesthesia

US Patents and Regulatory Information for PLIAGLIS

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharms PLIAGLIS lidocaine; tetracaine CREAM;TOPICAL 021717-001 Jun 29, 2006 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Accenture
McKesson
Johnson and Johnson
McKinsey
Deloitte
Mallinckrodt
Federal Trade Commission
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
DrugPatentWatch reviews  
Links

Follow DrugPatentWatch: